| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/05/2023 | 21.69% | Wolfe Research | → $84 | Upgrades | Peer Perform → Outperform |
| 08/03/2023 | 26.03% | Morgan Stanley | $87 → $87 | Reiterates | Overweight → Overweight |
| 05/09/2023 | 26.03% | Morgan Stanley | $80 → $87 | Maintains | Overweight |
| 04/18/2023 | -1.49% | Goldman Sachs | $60 → $68 | Maintains | Neutral |
| 04/17/2023 | 23.13% | Pivotal Research | $82 → $85 | Maintains | Buy |
| 04/14/2023 | 21.69% | Rosenblatt | $81 → $84 | Maintains | Buy |
| 03/09/2023 | 12.99% | JP Morgan | $75 → $78 | Maintains | Overweight |
| 03/02/2023 | 15.89% | Morgan Stanley | $75 → $80 | Maintains | Overweight |
| 11/07/2022 | -1.49% | Rosenblatt | $76 → $68 | Maintains | Buy |
| 08/09/2022 | 8.65% | Morgan Stanley | $72 → $75 | Maintains | Overweight |
| 08/08/2022 | -18.88% | Barclays | $50 → $56 | Maintains | Underweight |
| 06/15/2022 | 4.3% | Morgan Stanley | $65 → $72 | Upgrades | Equal-Weight → Overweight |
| 05/09/2022 | -27.57% | Barclays | $44 → $50 | Maintains | Underweight |
| 05/02/2022 | -5.84% | Morgan Stanley | $58 → $65 | Maintains | Equal-Weight |
| 04/26/2022 | 17.34% | Rosenblatt | → $81 | Initiates Coverage On | → Buy |
| 02/23/2022 | -5.84% | JP Morgan | $60 → $65 | Maintains | Overweight |
| 01/26/2022 | -15.98% | Morgan Stanley | $55 → $58 | Maintains | Equal-Weight |
| 07/28/2021 | -27.57% | Morgan Stanley | $46 → $50 | Maintains | Equal-Weight |
| 07/16/2021 | -30.47% | Goldman Sachs | → $48 | Initiates Coverage On | → Neutral |
| 05/06/2021 | -33.36% | Morgan Stanley | $44 → $46 | Maintains | Equal-Weight |
| 11/06/2020 | -36.26% | Morgan Stanley | $42 → $44 | Maintains | Equal-Weight |
| 09/03/2020 | -39.16% | Morgan Stanley | $32 → $42 | Maintains | Equal-Weight |
| 05/08/2020 | -53.64% | Morgan Stanley | $30 → $32 | Maintains | Equal-Weight |
| 03/18/2020 | -43.5% | B. Riley Securities | $47 → $39 | Maintains | Buy |
| 03/03/2020 | -31.91% | B. Riley Securities | $51 → $47 | Reiterates | → Buy |
| 12/13/2019 | -24.67% | Morgan Stanley | $48 → $52 | Maintains | Overweight |
| 08/15/2019 | -27.57% | JP Morgan | $38 → $50 | Upgrades | Neutral → Overweight |
| 05/16/2019 | -33.36% | B. Riley Securities | $35 → $46 | Upgrades | Neutral → Buy |
| 10/09/2018 | — | Goldman Sachs | Initiates Coverage On | → Neutral |
What is the target price for Liberty Formula One Group (FWONK)?
The latest price target for Liberty Formula One Group (NASDAQ: FWONK) was reported by Wolfe Research on September 5, 2023. The analyst firm set a price target for $84.00 expecting FWONK to rise to within 12 months (a possible 21.69% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Liberty Formula One Group (FWONK)?
The latest analyst rating for Liberty Formula One Group (NASDAQ: FWONK) was provided by Wolfe Research, and Liberty Formula One Group upgraded their outperform rating.
When is the next analyst rating going to be posted or updated for Liberty Formula One Group (FWONK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Liberty Formula One Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Liberty Formula One Group was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.
Is the Analyst Rating Liberty Formula One Group (FWONK) correct?
While ratings are subjective and will change, the latest Liberty Formula One Group (FWONK) rating was a upgraded with a price target of $0.00 to $84.00. The current price Liberty Formula One Group (FWONK) is trading at is $69.03, which is within the analyst's predicted range.